Completed OBSERVATIONAL NCT05060562

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population

Predictors of the Occurrence of Post Coronavirus Disease Syndrome Among COVID-19 Patients in Indonesia

Sponsor: Chulalongkorn University

Conditions Covid19

Interventions COVID 19 negative COVID 19 positive

Updated 8 times since 2021 Last updated: Nov 24, 2023 Started: Sep 1, 2021 Primary completion: Sep 1, 2023 Completion: Nov 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Chulalongkorn University leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Sep 2022 — Dec 2023 [monthly]

Recruiting

▶ Show 3 earlier versions

Jan 2022 — Sep 2022 [monthly]

Recruiting
Nov 2021 — Jan 2022 [monthly]

Recruiting
Oct 2021 — Nov 2021 [monthly]

Recruiting

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University
Hasanuddin University

Data source: Hasanuddin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Makassar, Indonesia
• Ternate, Indonesia